Xilio Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Xilio Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q3 2024.
  • Xilio Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 63.5M shares, a 131% increase year-over-year.
  • Xilio Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 27.5M shares, a 0.38% increase from 2022.
  • Xilio Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 27.4M shares, a 389% increase from 2021.
  • Xilio Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 5.61M shares, a 970% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 63.5M +35.9M +131% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 57.8M +30.3M +110% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 27.9M +479K +1.75% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 27.5M +104K +0.38% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 27.5M +124K +0.45% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 27.5M +84.1K +0.31% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 27.4M +65.9K +0.24% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 27.4M +21.8M +389% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 27.4M +26.6M +3487% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 27.4M +26.6M +3618% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 27.4M +26.7M +3764% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 5.61M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-02
Q3 2021 764K +151K +24.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 736K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 708K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 613K Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.